Refine by
Biopharmaceutical Articles & Analysis
877 news found
The additions to the leadership team are top-tier talent with a proven track record of success in the biopharmaceutical industry: Croom Lawrence, Chief Commercial Officer: With over 25 years of biotech commercial launch experience, Mr. ...
Following regulatory approval, Advanced Instruments, a wholly-owned subsidiary within Patricia Industries, has now completed its acquisition of Nova Biomedical, a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The enterprise value amounts to USD 2.2bn. ...
In addition to providing contract R&D and biologic manufacturing services for diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market, the company aims to continue to act as a trusted source for all researchers' assay development and manufacturing ...
Watertown, MA - June 29, 2025 - Biopharma PEG, a leading innovator in high-quality polyethylene glycol (PEG) derivatives, today announced it has successfully obtained Drug Master File (DMF) approval from the U.S. Food and Drug Administration (FDA) for its self-developed HZ-PEG-HZ (1K) product. The assigned DMF number is 041864. This significant achievement underscores Biopharma PEG's robust ...
Product information:https://en.huatengsci.com/product/N-Benzylhydroxylamine-hydrochloride.html About Huateng PharmaHunan Huateng Pharmaceutical Co., Ltd. is a world-leading supplier of PEG derivatives and pharmaceutical intermediates, offering R&D-to-commercial scale support for global biopharmaceutical customers. Our advanced manufacturing facilities and comprehensive ...
In addition to providing contract R&D and biologic manufacturing services for diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market, the company aims to continue to act as a trusted source for all researchers' assay development and manufacturing ...
(Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today announced the appointment of Leone Patterson to its Board of Directors and as Chair of the Board’s Audit Committee. ...
ByKalaris
Huateng Pharma is dedicated to providing robust support to the biopharmaceutical and chemical pharmaceutical industries. With a strong foundation in PEG technology and state-of-the-art CDMO facilities, the company offers a seamless transition from R&D laboratory supply to commercial-scale production. ...
Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of ...
Biopharma PEG, a leading manufacturer of high-quality polyethylene glycol (PEG) derivatives, today announced that its mPEG-pAld (20K) product has successfully achieved DMF (Drug Master File) registration with the U.S. Food and Drug Administration (FDA) under DMF number 040600. “We are thrilled to receive FDA DMF registration for our mPEG-pAld (20K) product,” said Sonia Lee, Marketing ...
CD Bioparticles is focused on improving the efficiency and accuracy of drug drug delivery research in the biopharmaceutical industry, delivering faster and more reliable results. To learn more about CD Bioparticles' innovative drug delivery solutions and its newly launched ordering system, please visit https://www.cd-bioparticles.net/. ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced it has successfully achieved ISO/IEC 27017:2015 and ISO/IEC 27018:2019 certifications for information security and privacy protection in its cloud services from BSI, the business improvement and standards company. It has also achieved recertification to ISO/IEC ...
At the same time, these services position Protheragen as a leading infectious disease contract service provider in the biopharmaceutical landscape, committed to improving global health through innovative vaccine solutions. ...
Monodispersed PEGs play a pivotal role in advancing drug development and innovation across the biopharmaceutical industry.Products Included in the Offer: mPEG36-NH2 N3-PEG6-OH N3-PEG11-NH2 OH-PEG9-OH N3-PEG3-COOH N3-PEG3-SPA And additional select monodispersed PEGsOur monodispersed PEGs are available in GMP-grade quality and scalable quantities, ranging from ...
Over the past decade, the use of the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanoderived therapeutics and their translation into commercially viable products has been proven to be highly effective in terms of maintaining the overall stability of pharmaceutical formulations. ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that Tennessee Oncology, one of the United States’ largest community-based cancer care specialists that treats nearly half of Tennessee’s cancer patients across 35 clinics, has expanded its relationship with SOPHiA GENETICS to advance its cancer research. ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, today announced the next step in the partnership between the Company and Genomenon, a leading genomic intelligence company, to support better, data-driven outcomes in the rare disease and oncology fields. The two companies have expanded the integration of Genomenon’s Mastermind® Genomic ...
In addition to providing contract R&D and biologic manufacturing services for diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market, the company aims to continue to act as a trusted source for all researchers' assay development and manufacturing ...
Watertown, MA — October 24, 2024 — Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development ...
By leveraging our cutting-edge technology and rigorous quality control measures, we provide our partners with reliable materials that can significantly enhance the efficacy of their cancer therapies. Furthermore, as the biopharmaceutical landscape continues to evolve, Huateng Pharma remains dedicated to advancing drug development through collaboration and innovation. ...